Results 271 to 280 of about 21,836 (300)

Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia.

AIDS (London), 2019
OBJECTIVES Treatment with trimethoprim-sulfamethoxazole for Pneumocystis pneumonia (PCP) is often associated with adverse effects. Echinocandins, by inhibiting the cyst form of Pneumocystis jirovecii, may be an alternative therapy for PCP.
Yu-Shan Huang, Chun-Eng Liu, Shi-ping Lin, Chen-Hsiang Lee, Chia-Jui Yang, Chi-Ying Lin, H. Tang, Yi-Chien Lee, Yi-Chun Lin, Yuan-Ti Lee, Hsin-Yun Sun, C. Hung   +11 more
semanticscholar   +1 more source

Molecular Detection of Resistance to Echinocandins

2016
In the last years, life-threatening fungal diseases have increased significantly, due to the rising number of human individuals susceptible to fungal infections, which are in part complicated by the emergence of antifungal drug-resistant pathogens.
Posteraro, Brunella, Vella, Antonietta, De Carolis, Elena, Sanguinetti, Maurizio   +3 more
openaire   +3 more sources

Anidulafungin: an echinocandin antifungal

Expert Opinion on Investigational Drugs, 2004
Anidulafungin (LY-303366, V-echinocandin trade mark, Vicuron Pharmaceuticals, Inc.) is a new echinocandin antifungal agent with broad spectrum activity against Candida and Aspergillus spp. Anidulafungin exhibits low toxicity, concentration-dependent fungicidal activity for Candida, and a prolonged post antifungal effect (> 12h).
openaire   +2 more sources

Echinocandins in invasive candidiasis

Mycoses, 2013
SummaryWe summarise a recent meeting, sponsored by Pfizer Inc., where experts in Asia shared their clinical experience in managingIC. The echinocandins have demonstrated good activity against non‐albicansinfections and also azole‐resistant strains, both preclinically and in recent clinical trials.
George Dimopoulos, Siriporn Wittayachanyapong, B. Shoib Mohd Sany, Melor Mansor, Hoe Nam Leong, Marie Yvette C. Barez, Sheng-Fong Lin, Hsin-Yun Sun, Atul Patel, Bambang Wahjuprajitno, John Simon, Deepak Talwar, Po-Yen Huang, Jen-Hsien Wang   +13 more
openaire   +2 more sources

Clinical efficacy of echinocandin antifungals

Current Opinion in Infectious Diseases, 2001
The prevalence of fungal infections has increased significantly over the past few decades. Candida and Aspergillus spp. are the most common fungal pathogens due to recent changes in medical technology. Amphotericin B continues to be the treatment of choice in many severe disseminated mycosis cases, but problems with toxicity, resistance and non ...
openaire   +3 more sources

Caspofungin: An echinocandin antifungal agent

Clinical Therapeutics, 2002
The mainstays of treatment for nosocomial fungal infections have been amphotericin B and azole derivatives. Caspofungin acetate is a new echinocandin antifungal agent with a mechanism of action that targets a structural component of the fungal cell wall.This article describes the pharmacologic properties and potential clinical usefulness of caspofungin.
Horatio B. Fung, Elizabeth A. Stone, Harold L. Kirschenbaum   +2 more
openaire   +3 more sources

New developments and directions in the clinical application of the echinocandins

Archives of Toxicology, 2017
Christina C. Chang, M. Slavin, S. Chen, S. Chen   +3 more
exaly   +2 more sources

Echinocandin antifungals: review and update

Expert Review of Anti-infective Therapy, 2006
The echinocandins are a new and unique class of antifungal agents that act on the fungal cell wall by way of noncompetitive inhibition of the synthesis of 1,3-beta-glucans. All agents of this class are of parenteral formulation, with no oral preparations available.
openaire   +3 more sources

Echinocandin-Resistenzen in \(Candida\) \(glabrata\)

2022
Candida glabrata ist die zweithäufigste Ursache von Candidämien und invasiven Hefepilzinfektionen in Europa. Im Gegensatz zu C. albicans zeigt C. glabrata eine reduzierte Empfindlichkeit gegen bestimmte Antimykotika und kann unter Therapie rasch Resistenzen entwickeln.
openaire   +1 more source

Echinocandins in the Treatment of Aspergillosis

2014
In the presence of caspofungin, blunting and abnormal branching of the hyphae in actively growing areas of the cell are observed, primarily at the tips and branching points. These observations are consistent with the mechanism of action but do not fit the classical definitions of a fungicidal or fungistatic agent. Echinocandins are large molecules with
Vincent Maertens, Johan Maertens
openaire   +2 more sources